Replies to post #418963 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

Alzheimer’s patients were chomping at the bit for Aduhelm and demanding Medicare reimbursement despite the drug’s known side effects and limited benefits. For example: https://www.newsmax.com/health/health-news/alzheimers-aduhelm-medicare-coverage/2022/01/21/id/1053373/

Desperate patients clinging to hope will try just about anything in the hope of seeing some improvement.

To assume that patients are chomping at the bit for Blarcamesine because they are seeing significant improvements might be right but it’s also possible patients are desperate and will look to try something that might give them hope when nothing else is available to them.

“Desperation” and “hope” are the operative words.